Thioacetazone

Thioacetazone is an antibiotic that was previously used to treat tuberculosis. It is also known as amithiozone. Thioacetazone is not commonly used today due to its side effects, which include skin rashes and potentially fatal Stevens-Johnson syndrome.

History

Thioacetazone was first synthesized in the 1940s and was widely used in the treatment of tuberculosis in the mid-20th century. However, its use declined in the late 20th century due to the emergence of more effective and less toxic drugs.

Pharmacology

Thioacetazone works by inhibiting the synthesis of mycolic acid, a key component of the cell wall of Mycobacterium tuberculosis, the bacterium that causes tuberculosis.

Side effects

The most common side effects of thioacetazone are skin rashes, which can be severe. In rare cases, thioacetazone can cause Stevens-Johnson syndrome, a serious and potentially fatal skin condition. Other side effects include hepatotoxicity and blood disorders.

Current use

Today, thioacetazone is rarely used due to its side effects and the availability of more effective and less toxic drugs. However, it may still be used in some cases when other treatments are not effective or cannot be used.

See also

• Tuberculosis treatment
• Antibiotics
• Stevens-Johnson syndrome

Thioacetazone Resources
Latest articles Most recent articles Ongoing trials	Wikipedia